The global clinical trials market size is expected to reach USD 69.8 billion by 2027, exhibiting a 5.1% CAGR during the forecast period, according to a new report published by Grand View Research, Inc. Increasing incidence of diabetes, rheumatoid arthritis, multiple sclerosis and many other chronic diseases is projected to propel the growth. Due to rising prevalence of infectious and tropical diseases in some regions, a large number of patients is participating in clinical trials to access high quality healthcare treatment free of cost.
Increasing prevalence of life-threatening allergic diseases is also expected to fuel the market growth. As per the Food Allergy Research & Education Survey 2017, around 200,000 people need emergency medical care for allergic reaction to food, mostly in U.S. In addition, government initiative has also motivated many players in market to initiate orphan drug development. Thus there are various drugs in pipeline. Rising healthcare expenditure and collaborations for the purpose of R&D activities are also expected to be other significant factors driving the market for clinical trials in the forthcoming years.
Request a sample Copy of the Clinical Trials Market Research Report @ https://www.grandviewresearch.com/industry-analysis/global-clinical-trials-market/request/rs1
Key Takeaways Of The Report :
-
Phase III clinical trials emerged as the largest segment in 2019
-
Interventional study design segment held the largest market share in 2019, owing to increasing demand for the intervention for clinical trials by researchers
-
North America dominated the clinical trials market with the largest revenue share in 2019. Increasing demand for new technologies along with advanced healthcare infrastructure are contributing to the dominance of this region
-
Asia Pacific is projected to witness the fastest growth during the forecast period owing to the increasing number of diabetic patients in this region
-
Few of the market players include IQVIA; PAREXEL International Corporation; Pharmaceutical Product Development, LLC; Charles River Laboratory; ICON Plc; Wuxi AppTec Inc.; PRA Health Sciences; SGS SA; Syneos Health; Chiltern International Ltd.; Eli Lilly and Company; Novo Nordisk A/S; Pfizer; and Clinipace
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/1332/ibb
Grand View Research has segmented the global clinical trials market based on phase, study design, indication, and region:
Clinical Trials Phase Outlook (Revenue, USD Million, 2016 – 2027)
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 – 2027)
-
Interventional
-
Observational
-
Expanded Access
Clinical Trials Indication Outlook (Revenue, USD Million, 2016 – 2027)
-
Autoimmune/Inflammation
-
Pain Management
-
Cardiovascular
-
CNS Condition
-
Oncology
-
Diabetes
-
Obesity
-
Others
Clinical Trials Regional Outlook (Revenue, USD Million, 2016 – 2027)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
U.K.
-
Germany
-
France
-
Spain
-
Italy
-
-
Asia Pacific
-
India
-
Japan
-
China
-
Australia
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Colombia
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
Browse Related Report:
Clinical Workflow Solutions Market : https://www.grandviewresearch.com/industry-analysis/clinical-workflow-solutions-market
eClinical Solutions Market : https://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/global-clinical-trials-market